Skip to Content

WATSON 761 (Ranitidine Hydrochloride 300 mg)

Pill with imprint WATSON 761 is Beige, Elliptical / Oval and has been identified as Ranitidine Hydrochloride 300 mg. It is supplied by Watson Pharmaceuticals.

Ranitidine is used in the treatment of duodenal ulcer; gerd; erosive esophagitis; cutaneous mastocytosis; duodenal ulcer prophylaxis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 761

Ranitidine hydrochloride 300 mg WATSON 761

Ranitidine Hydrochloride

Imprint
WATSON 761
Strength
300 mg
Color
Beige
Size
16.00 mm
Shape
Elliptical / Oval
Availability
Rx and/or OTC
Drug Class
H2 antagonists
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
National Drug Code (NDC)
00591-0761

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.